POMC and hypophysitis: As far as hypophysitis is concerned, patients with ipilimumab-induced hypophysitis may develop antibodies against thyroid-stimulating hormone (TSH) secreting cells and some of them may also develop antibodies against follicle-stimulating hormone-secreting or adrenocorticotropic hormone (ACTH) secreting cells [94].